MedPath

AMARANTH MEDICAL INC.

๐Ÿ‡ฎ๐Ÿ‡นItaly
Ownership
-
Employees
-
Market Cap
-
Website

Safety and Efficacy Study of the Amaranth Medical MAGNITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT III)

Phase 2
Conditions
Myocardial Ischemia
Coronary Artery Disease
Interventions
Device: AmM MAGNITUDE Bioresorbable Drug-Eluting Coronary Scaffold
First Posted Date
2016-09-15
Last Posted Date
2016-11-25
Lead Sponsor
Amaranth Medical Inc.
Target Recruit Count
70
Registration Number
NCT02900937
Locations
๐Ÿ‡ฎ๐Ÿ‡น

Policlinico San Donato, Milano, Italy

๐Ÿ‡จ๐Ÿ‡ด

Instituto del Corazon, Bucaramanga, Colombia

๐Ÿ‡ฎ๐Ÿ‡น

IRCCS Instituto Clinico Humanitas, Milano, Italy

and more 10 locations

Safety and Efficacy Study of the Amaranth Medical APTITUDE Bioresorbable Drug-Eluting Coronary Stent

Phase 2
Conditions
Myocardial Ischemia
Coronary Artery Disease
Interventions
Device: AmM APTITUDE Bioresorbable Drug-Eluting Coronary Scaffold
First Posted Date
2015-10-06
Last Posted Date
2016-06-08
Lead Sponsor
Amaranth Medical Inc.
Target Recruit Count
60
Registration Number
NCT02568462
Locations
๐Ÿ‡จ๐Ÿ‡ด

Clinica de Marly, Bogota, Colombia

๐Ÿ‡ฎ๐Ÿ‡น

Ospedale San Raffaele, Milano, Italy

๐Ÿ‡ฎ๐Ÿ‡น

Azienda Policlinico-Vittorio Emanuele, Universita di Catania, Catania, Italy

and more 9 locations

Safety and Efficacy Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent

Phase 2
Conditions
Coronary Artery Disease
Myocardial Ischemia
Interventions
Device: AmM FORTITUDE Bioresorbable Drug-Eluting Coronary Scaffold
First Posted Date
2014-10-03
Last Posted Date
2016-06-08
Lead Sponsor
Amaranth Medical Inc.
Target Recruit Count
21
Registration Number
NCT02255864
Locations
๐Ÿ‡ฎ๐Ÿ‡น

Azienda Policlinico-Vittorio Emanuele, Universita di Catania, Catania, Italy

๐Ÿ‡ฎ๐Ÿ‡น

Ospedale San Raffaele, Milano, Italy

๐Ÿ‡ฎ๐Ÿ‡น

A. O. U. Federico IIหš Policlinico, Napoli, Italy

and more 2 locations

Feasibility Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent

Phase 2
Conditions
Coronary Artery Disease
Myocardial Ischemia
Interventions
Device: AmM FORTITUDE Bioresorbable Drug-Eluting Coronary Scaffold
First Posted Date
2014-07-14
Last Posted Date
2016-06-08
Lead Sponsor
Amaranth Medical Inc.
Target Recruit Count
42
Registration Number
NCT02189499
Locations
๐Ÿ‡จ๐Ÿ‡ด

Instituto del Corazon, Bucaramanga, Colombia

๐Ÿ‡จ๐Ÿ‡ด

Clinica de Marly, Bogota, Colombia

๐Ÿ‡จ๐Ÿ‡ด

Angiografia De Occidente S.A., Cali, Colombia

and more 1 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath